Lakhmir S. Chawla, Chief Medical Officer at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 3,000 shares at $5.57 ($17K) on 2019-01-29, disclosed to the SEC on 2019-01-31.
Open-market purchase of $17k LJPC by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.55 | 800 | $4K | 26.6% |
| 2 | $5.57 | 1,200 | $7K | 40.0% |
| 3 | $5.57 | 200 | $1K | 6.7% |
| 4 | $5.57 | 800 | $4K | 26.7% |
| Total | $5.56 avg | 3,000 | $17K | 100% |
| Filing → |